Laccetti AL, Bodei L, O'Donoghue JA, Weber WA, et al. A Phase 1, Open-label, Dose-Ascending Study to Evaluate the Safety and Tolerability of the Therapeutic Radiopharmaceutical 131I-MIP-1095 for the Treatment of Metastatic Castration-Resistant Prostate Cancer. Clin Nucl Med 2023;48:937-944.
PMID: 37812518